Use of antidepressant medications among older adults in European long-term care facilities: a cross-sectional analysis from the SHELTER study
Jazyk angličtina Země Anglie, Velká Británie Médium electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
32854659
PubMed Central
PMC7457305
DOI
10.1186/s12877-020-01730-5
PII: 10.1186/s12877-020-01730-5
Knihovny.cz E-zdroje
- Klíčová slova
- Antidepressants, Nursing homes, Older adults,
- MeSH
- antidepresiva * terapeutické užití MeSH
- dlouhodobá péče * MeSH
- lidé MeSH
- longitudinální studie MeSH
- průřezové studie MeSH
- senioři MeSH
- Check Tag
- lidé MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa epidemiologie MeSH
- Izrael epidemiologie MeSH
- Názvy látek
- antidepresiva * MeSH
BACKGROUND: Late-life depression is common among older adults living in nursing homes (NHs). Over the last 30 years there has been an increase in the rates of prescription of antidepressant medications across all ages, with the largest rise reported in older adults. This study aimed to describe the pattern of antidepressant medication use among NH residents from 7 European countries and Israel and to examine patient and facilities characteristics that may account for it. METHODS: We conducted a cross-sectional analysis of data from the SHELTER study, an observational longitudinal cohort study that collected comprehensive resident data using the interRAI Long-Term Care Facility instrument in 7 European Countries and Israel. Descriptive statistics were used to examine sample characteristics. Potential correlates of antidepressant medication use were identified using multiple logistic regression modeling. RESULTS: Among 4023 residents entering the study, 32% had depressive symptoms and nearly half of these individuals used antidepressants. Antidepressant medication use varied by country, with a prevalence in the overall sample of 35.6% (n = 1431). Among antidepressant users, 59.9% were receiving selective serotonin reuptake inhibitors (SSRI). The strongest correlates of antidepressant use included reported diagnosis of anxiety, depression, bipolar disorder, pain, falls and high level of social engagement. Age over 85 years, living in facilities located in rural areas and a diagnosis of schizophrenia reduced the likelihood of being prescribed with an antidepressant. CONCLUSIONS: A large proportion of residents in European long-term care facilities receive antidepressant medications. The decision to prescribe antidepressants to NH residents seems to be influenced by both patient and facility characteristics. Future longitudinal studies should evaluate the efficacy and safety of antidepressant use in NHs thus providing evidence for recommendations for clinical practice.
AGAPLESION Bethesda Clinic Competence Centre of Geriatrics University of Ulm Ulm Germany
Department of Geriatrics 1st Faculty of Medicine Charles University Prague Czech Republic
Fondazione Policlinico Universitario A Gemelli IRCCS Università Cattolica del Sacro Cuore Rome Italy
Zobrazit více v PubMed
Blazer DG. Depression in late life: review and commentary. J Gerontol Series A Biol Scie Med Sci. 2003;58:249–265. doi: 10.1093/gerona/58.3.M249. PubMed DOI
Horackova K, Kopecek M, Machů V, Kagstrom A, Aarsland D, Motlova LB, Cermakova P. Prevalence of late-life depression and gap in mental health service use across European regions. Eur Psychiatry. 2019;57:19–25. doi: 10.1016/j.eurpsy.2018.12.002. PubMed DOI
She R, Yan Z, Jiang H, Vetrano DL, Lau JTF, Qiu C. Multimorbidity and health-related quality of life in old age: role of functional dependence and depressive symptoms. J Am Med Dir Assoc. 2019;20(9):1143–1149. doi: 10.1016/j.jamda.2019.02.024. PubMed DOI
Gathright EC, Goldstein CM, Josephson RA, Hughes JW. Depression increases the risk of mortality in patients with heart failure: a meta-analysis. J Psychosom Res. 2017;94:82–89. doi: 10.1016/j.jpsychores.2017.01.010. PubMed DOI PMC
Gallo JJ, Lebowitz BD. The epidemiology of common late-life mental disorders in the community: themes for the new century. Psychiatr Serv. 1999;50(9):1158–1166. doi: 10.1176/ps.50.9.1158. PubMed DOI
Thakur M, Blazer DG. Depression in long-term care. J Am Med Dir Assoc. 2008;9(2):82–87. doi: 10.1016/j.jamda.2007.09.007. PubMed DOI
Chau R, Kissane DW, Davison TE. Risk factors for depression in long-term care: a prospective observational cohort study. Clin Gerontol. 2019;2:1–14. doi: 10.1080/07317115.2019.1635548. PubMed DOI
Hanlon JT, Handler SM, Castle NG. Antidepressant prescribing in US nursing homes between 1996 and 2006 and its relationship to staffing patterns and use of other psychotropic medications. J Am Med Dir Assoc. 2010;11:320–324. doi: 10.1016/j.jamda.2010.01.007. PubMed DOI PMC
Kane KD, Yochim BP, Lichtenberg PA. Depressive symptoms and cognitive impairment predict all-cause mortality in long-term care residents. Psychol Aging. 2010;25(2):446–452. doi: 10.1037/a0019032. PubMed DOI PMC
Alexopoulos GS. Depression in the elderly. Lancet. 2005;365(9475):1961–1970. doi: 10.1016/S0140-6736(05)66665-2. PubMed DOI
American Medical Directors Association. Depression in the long-term care setting clinical practice guideline. Columbia: AMDA; 2011.
Shah S, Schoenbachler B, Streim J, Meeks S. Antidepressant prescribing patterns in the nursing home: second-generation issues revisited. J Am Med Dir Assoc. 2012;13(4):406. doi: 10.1016/j.jamda.2011.09.004. PubMed DOI PMC
Vetrano DL, Villani ER, Grande G, Giovannini S, Cipriani MC, Manes-Gravina E, Bernabei R, Onder G. Association of Polypharmacy with 1-year trajectories of cognitive and physical function in nursing home residents: results from a multicenter European study. J Am Med Dir Assoc. 2018;19(8):710–713. doi: 10.1016/j.jamda.2018.04.008. PubMed DOI
Vetrano DL, Collamati A, Magnavita N, Sowa A, Topinkova E, Finne-Soveri H, van der Roest HG, Tobiasz-Adamczyk B, Giovannini S, Ricciardi W, Bernabei R, Onder G, Poscia A. Health determinants and survival in nursing home residents in Europe: results from the SHELTER study. Maturitas. 2018;107:19–25. doi: 10.1016/j.maturitas.2017.09.014. PubMed DOI
Paquay L, De Lepeleire J, Schoenmakers B, Ylieff M, Fontaine O, Buntinx F. Comparison of the diagnostic accuracy of the Cognitive Performance Scale (Minimum Data Set) and the Mini-Mental State Exam for the detection of cognitive impairment in nursing home residents. Int. J. Geriatr. Psychiatry. 2007;22(4):286–293. doi: 10.1002/gps.1671. PubMed DOI
Burrows AB, Morris JN, Simon SE, Hirdes JP, Phillips C. Development of a minimum data set-based depression rating scale for use in nursing homes. Age Ageing. 2000;29(2):165–172. doi: 10.1093/ageing/29.2.165. PubMed DOI
Boyce RD, Hanlon JT, Karp JF, Kloke J, Saleh A, Handler SM. A review of the effectiveness of antidepressant medications for depressed nursing home residents. J Am Med Dir Assoc. 2012;13:326–331. doi: 10.1016/j.jamda.2011.08.009. PubMed DOI PMC
Cherma MD, Lofgren U, Almkvist G, et al. Assessment of the prescription of antidepressant drugs in elderly nursing home patients. J Clin Psychopharm. 2008;28(4):424–431. doi: 10.1097/JCP.0b013e31817d79eb. PubMed DOI
Brown MN, Lapane K, Luisi AF. The management of depression in older nursing home residents. J Am Geriatr Soc. 2002;50:69–72. doi: 10.1046/j.1532-5415.2002.50010.x. PubMed DOI
Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;343:d4551. doi: 10.1136/bmj.d4551. PubMed DOI PMC
French DD, Campbell RR, Spehar AM, Rubenstein LZ, Cunningham FE. Drug costs and use in VHA nursing homes: a national overview of long-stay residents. J Am Med Dir Assoc. 2007;8(8):515–518. doi: 10.1016/j.jamda.2007.02.001. PubMed DOI
Selbaek G, Kirkevold Ø, Engedal K. The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. Int J Geriatr Psychiatry. 2007;22(9):843–849. doi: 10.1002/gps.1749. PubMed DOI
Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev. 2006;1:CD003491. PubMed PMC
Kelton CM, Rebelein RP, Heaton PC, Ferrand Y, Guo JJ. Differences in the cost of antidepressants across state Medicaid programs. J Ment Health Policy Econ. 2008;11(1):33–47. PubMed
Karkare SU, Bhattacharjee S, Kamble P, Aparasu R. Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States. Am J Geriatr Pharmacother. 2011;9(2):109–119. doi: 10.1016/j.amjopharm.2011.03.001. PubMed DOI
Rigler SK, Perera S, Redford L, Studenski S, Brown EF, Wallace D, Webb M. Urban-rural patterns of increasing antidepressant use among nursing facility residents. J Am Med Dir Assoc. 2003;4(2):67–73. doi: 10.1016/S1525-8610(04)70278-9. PubMed DOI
Kang H. Correlates of social engagement in nursing home residents with dementia. Asian Nurs Res (Korean Soc Nurs Sci) 2012;6(2):75–81. PubMed
Janakiraman R, Hamilton L, Wan A. Unravelling the efficacy of antidepressants as analgesics. Aust Fam Physician. 2016;45(3):113–117. PubMed
Chu L, Schnelle JF, Osterweil D. Prescription analgesic and antidepressant utilization and cost among elderly Medicaid beneficiaries before and after nursing home admission. J Am Med Dir Assoc. 2004;5(2):75–81. doi: 10.1016/S1525-8610(04)70059-6. PubMed DOI
López-Lopez A, González JL, Alonso-Fernández M, Cuidad N, Matías B. Pain and symptoms of depression in older adults living in community and in nursing homes: the role of activity restriction as a potential mediator and moderator. Int Psychogeriatr. 2014;26(10):1679–1691. doi: 10.1017/S1041610214000970. PubMed DOI
Milos V, Bondesson Å, Magnusson M, Jakobsson U, Westerlund T, Midlöv P. Fall risk-increasing drugs and falls: a cross-sectional study among elderly patients in primary care. BMC Geriatr. 2014;14:40. doi: 10.1186/1471-2318-14-40. PubMed DOI PMC